Legal Information

Company - Legal Information

General Sales Terms and Conditions

Santa Clara County, California, USA, shall be the venue for any litigation related to the dissemination of information on this web site. Purchaser agrees that the venue for litigation arising out of the purchase and/or use of any products mentioned herein shall be Santa Clara, California, USA. All Prices are quoted FOB Sunnyvale, CA.

Legal Notices

Our United States Patent 6,101,946 protects TeleChem’s 946, Stealth, ChipMaker, and related microarray printing technologies from unauthorized manufacture, use, sale and import. The vast majority of our customers, suppliers, vendors, collaborators, and employees respect our intellectual property and trade secrets, and we appreciate their professionalism. In a few instances, unscrupulous parties have attempted to misappropriate our technology by making “knock-off” Pins and Printheads and by divulging and selling our trade secrets for financial gain. We take these illegal activities seriously and can and will enforce our patents, contracts, and non-disclosure agreements vigorously. Please contact our legal department if you have any questions concerning legal matters. The purchase of one of our micro spotting devices provides a license for research purposes only, and any other use such as for diagnostics requires a license.

The United States Patent and Trademark Office (USPTO) awarded TeleChem International, Inc. a landmark patent in the field of genotyping and human diagnostics. United States Patent 6,913,879 entitled “Microarray method of genotyping multiple samples at multiple loci” gives the company a major patent position in the rapidly expanding medical diagnostics market. Based on pioneering research by the company’s Visiting Scholar Dr. Mark Schena, our 879’ patent teaches methods of genotyping many patients at once, rather than one patient at a time as with traditional approaches. TeleChem’s patented multi-patient methods are rapid, accurate and highly cost-effective. In one embodiment, the “Schena patent” places spots of patient DNA on a glass substrate, allowing as many as 100,000 patients to be screened in a single microarray test. The massively parallel multi-patient format reduces the cost of genotyping by 1,000-fold and ensures 100% accuracy.

Oligonucleotide Arrays: TeleChem International, Inc. is not licensed under any patents owned by Oxford Gene Technology Ltd. ("OGT"). A license to OGT patents may be necessary to manufacture or use certain arrays. To inquire about a license to OGT's oligonucleotide array patents, please contact licensing@ogt.

TeleChem International is not licensed under any patents for sequencing by hybridization owned by Hyseq.

The PCR process is covered by a series of U.S. and foreign patents issued to Hoffman-LaRoche, Inc.

Any opinions expressed on this website are those of TeleChem International, Inc. The unauthorized use, disclosure, copying or alteration of this website is strictly forbidden. All web content and emails from TeleChem, including attachments have been scanned for viruses prior to leaving the arrayit.com network. TeleChem is not be liable for direct, special, indirect or consequential damages as a result of any virus being passed on, or arising from alteration of the contents of this website, or any file sent from the arrayit.com network.

Contact
Ms. Rene Schena
President
Phone: (408) 744-1331
FAX: (408) 744-1711
Email: rene@arrayit.com